Immunocore Holdings plc
IMCR
$37.88
$1.714.73%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.10% | 26.78% | 25.75% | 24.37% | 24.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.10% | 26.78% | 25.75% | 24.37% | 24.32% |
| Cost of Revenue | -121.62% | -97.13% | -59.69% | -725.76% | -103.46% |
| Gross Profit | 29.68% | 30.29% | 29.10% | 47.63% | 228.73% |
| SG&A Expenses | 6.58% | 3.88% | 3.62% | 7.81% | -6.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -2,112.37% | -2,112.37% | -2,112.37% | -2,112.37% | 12,914.29% |
| Total Operating Expenses | 11.33% | 8.16% | 7.55% | 16.98% | 17.14% |
| Operating Income | 60.75% | 61.94% | 59.17% | 13.44% | 6.15% |
| Income Before Tax | 47.68% | 62.22% | 65.40% | 13.06% | -5.94% |
| Income Tax Expenses | 116.36% | 52.25% | 79.31% | 66.98% | -137.17% |
| Earnings from Continuing Operations | 37.88% | 62.99% | 64.12% | 7.60% | 31.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 37.88% | 62.99% | 64.12% | 7.60% | 31.62% |
| EBIT | 60.75% | 61.94% | 59.17% | 13.44% | 6.15% |
| EBITDA | 63.84% | 65.16% | 62.62% | 14.61% | 6.07% |
| EPS Basic | 38.37% | 63.26% | 64.53% | 9.74% | 33.70% |
| Normalized Basic EPS | 45.11% | 59.78% | 63.37% | 21.13% | -6.44% |
| EPS Diluted | 38.68% | 62.84% | 64.15% | 9.37% | 33.33% |
| Normalized Diluted EPS | 45.39% | 59.25% | 62.89% | 20.71% | -6.92% |
| Average Basic Shares Outstanding | 0.69% | 0.95% | 1.49% | 2.26% | 2.79% |
| Average Diluted Shares Outstanding | 0.23% | 0.74% | 1.26% | 1.08% | 1.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |